REPORT ID 2507

China Respiratory Inhaler Market Research Report 2017

Publish Date
8-Dec-17
Pages
95
Format
Electronic (PDF)

The global Respiratory Inhaler market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Respiratory Inhaler development status and future trend in China, focuses on top players in China, also splits Respiratory Inhaler by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Koninklijke Philips
    Omron Healthcare
    Merck
    Cipla
    GlaxoSmithKline
    PARI Medical Holding
    Teva Pharmaceutical Industries
    AstraZeneca
    Beximco Pharmaceuticals
    Boehringer Ingelheim

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Dry Powder Inhaler
    Metered Dose Inhaler
    Nebulizer

On the basis of the end users/application, this report covers
    Hospital and Clinic
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Respiratory Inhaler Market Research Report 2017
1 Respiratory Inhaler Overview
    1.1 Product Overview and Scope of Respiratory Inhaler
    1.2 Classification of Respiratory Inhaler by Product Category
        1.2.1 China Respiratory Inhaler Sales (K Units) Comparison by Type (2012-2022)
        1.2.2 China Respiratory Inhaler Sales (K Units) Market Share by Type in 2016
        1.2.3 Dry Powder Inhaler
        1.2.4 Metered Dose Inhaler
        1.2.5 Nebulizer
    1.3 China Respiratory Inhaler Market by Application/End Users
        1.3.1 China Respiratory Inhaler Sales (K Units) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital and Clinic
        1.3.3 Home Care
    1.4 China Respiratory Inhaler Market by Region
        1.4.1 China Respiratory Inhaler Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.3 East China Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.4 Southwest China Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.5 Northeast China Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.6 North China Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.7 Central China Respiratory Inhaler Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Respiratory Inhaler (2012-2022)
        1.5.1 China Respiratory Inhaler Sales (K Units) and Growth Rate (%)(2012-2022)
        1.5.2 China Respiratory Inhaler Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Respiratory Inhaler Market Competition by Players/Manufacturers
    2.1 China Respiratory Inhaler Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Respiratory Inhaler Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Respiratory Inhaler Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.4 China Respiratory Inhaler Market Competitive Situation and Trends
        2.4.1 China Respiratory Inhaler Market Concentration Rate
        2.4.2 China Respiratory Inhaler Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Respiratory Inhaler Manufacturing Base Distribution, Sales Area, Product Types

3 China Respiratory Inhaler Sales and Revenue by Region (2012-2017)
    3.1 China Respiratory Inhaler Sales (K Units) and Market Share by Region (2012-2017)
    3.2 China Respiratory Inhaler Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Respiratory Inhaler Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Respiratory Inhaler Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Respiratory Inhaler Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Respiratory Inhaler Price (USD/Unit) by Type (2012-2017)
    4.4 China Respiratory Inhaler Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Respiratory Inhaler Sales (K Units) and Market Share by Application (2012-2017)
    5.2 China Respiratory Inhaler Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Respiratory Inhaler Players/Suppliers Profiles and Sales Data
    6.1 Koninklijke Philips
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Respiratory Inhaler Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Koninklijke Philips Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Omron Healthcare
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Respiratory Inhaler Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Omron Healthcare Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Respiratory Inhaler Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cipla
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Respiratory Inhaler Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cipla Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GlaxoSmithKline
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Respiratory Inhaler Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GlaxoSmithKline Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 PARI Medical Holding
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Respiratory Inhaler Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 PARI Medical Holding Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Teva Pharmaceutical Industries
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Respiratory Inhaler Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Teva Pharmaceutical Industries Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 AstraZeneca
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Respiratory Inhaler Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AstraZeneca Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Beximco Pharmaceuticals
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Respiratory Inhaler Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beximco Pharmaceuticals Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Boehringer Ingelheim
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Respiratory Inhaler Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Boehringer Ingelheim Respiratory Inhaler Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview

7 Respiratory Inhaler Manufacturing Cost Analysis
    7.1 Respiratory Inhaler Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Respiratory Inhaler

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Respiratory Inhaler Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Respiratory Inhaler Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Respiratory Inhaler Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Respiratory Inhaler Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Respiratory Inhaler Sales (K Units) Forecast by Type (2017-2022)
    11.3 China Respiratory Inhaler Sales (K Units) Forecast by Application (2017-2022)
    11.4 China Respiratory Inhaler Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List